Chad M. Cohen, Chief Financial Officer at Adaptive Biotechnologies Corp (ADPT), sold 30,000 shares at $37.85 ($1.1M) on 2021-06-08, disclosed to the SEC on 2021-06-10.
Open-market sale of $1.1M ADPT by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $36.90 | 8,401 | $310K | 28.3% |
| 2 | $36.90 | 8,401 | $310K | 28.3% |
| 3 | $37.85 | 1,599 | $61K | 5.5% |
| 4 | $37.85 | 1,599 | $61K | 5.5% |
| 5 | $35.60 | 10,000 | $356K | 32.5% |
| Total | $36.57 avg | 30,000 |
| $1.1M |
| 100% |
| Filing → |
| ADPT | SELL | 2021-10-07 | $324K | — | Filing → |
| ADPT | SELL | 2021-09-09 | $940K | — | Filing → |
| ADPT | SELL | 2021-08-12 | $804K | — | Filing → |